Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and womenís health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under JOHNSONíS, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VEND‘ME, LISTERINE, REACH, BAND-AID, NEOSPORIN, CAREFREE, o.b., STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC names. This segment markets its products to the general public, as well as to retail outlets and distributors. The companyís Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and womenís health products; minimally invasive surgical and sterilization products; blood glucose monitoring and insulin delivery products; professional diagnostic products; and disposable contact lenses. This segment distributes its products directly and through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.